In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin. Field TS. Ann Intern Med 2024;177:JC65.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Field TS. In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin. Ann Intern Med 2024;177:JC65.
PMID: 38830225